Conolidine’s analgesic consequences stem from its conversation with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors within the central anxious system, conolidine modulates alternate molecular targets. A Science Advances study observed that conolidine interacts Using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability... https://helens998gse3.nytechwiki.com/user